Editorial
doi: 10.1213/ANE.0b013e31823acb95.
Remimazolam: new beginnings or just a me-too?
- PMID: 22826518
- DOI: 10.1213/ANE.0b013e31823acb95
Item in Clipboard
Editorial
Remimazolam: new beginnings or just a me-too?
Anesth Analg.
2012 Aug.
No abstract available
Comment on
-
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.Anesth Analg. 2012 Aug;115(2):274-83. doi: 10.1213/ANE.0b013e31823f0c28. Epub 2011 Dec 20. Anesth Analg. 2012. PMID: 22190555 Clinical Trial.
-
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.Anesth Analg. 2012 Aug;115(2):284-96. doi: 10.1213/ANE.0b013e318241f68a. Epub 2012 Jan 16. Anesth Analg. 2012. PMID: 22253270 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
